[HTML][HTML] Steroid-refractory chronic graft-versus-host disease: treatment options and patient management
Chronic graft-versus-host disease (cGVHD) is one of the major causes of late mortality after
allogenic hematopoietic stem cell transplantation. Moderate-to-severe cGVHD is associated …
allogenic hematopoietic stem cell transplantation. Moderate-to-severe cGVHD is associated …
Steroid-refractory chronic graft-versus-host disease: treatment options and patient management
D Wolff, G Fatobene, V Rocha… - Bone marrow …, 2021 - pubmed.ncbi.nlm.nih.gov
Chronic graft-versus-host disease (cGVHD) is one of the major causes of late mortality after
allogenic hematopoietic stem cell transplantation. Moderate-to-severe cGVHD is associated …
allogenic hematopoietic stem cell transplantation. Moderate-to-severe cGVHD is associated …
[引用][C] Steroid-refractory chronic graft-versus-host disease: treatment options and patient management
D Wolff, G Fatobene, VG Rocha… - Bone marrow …, 2021 - repositorio.usp.br
ReP USP - Detalhe do registro: Steroid-refractory chronic graft-versus-host disease: treatment
options and patient management Home About USP Schools USP Schools Escola de Artes …
options and patient management Home About USP Schools USP Schools Escola de Artes …
[HTML][HTML] Steroid-refractory chronic graft-versus-host disease: treatment options and patient management
D Wolff, G Fatobene, V Rocha, N Kröger… - Bone Marrow …, 2021 - ncbi.nlm.nih.gov
Chronic graft-versus-host disease (cGVHD) is one of the major causes of late mortality after
allogenic hematopoietic stem cell transplantation. Moderate-to-severe cGVHD is associated …
allogenic hematopoietic stem cell transplantation. Moderate-to-severe cGVHD is associated …
[PDF][PDF] Steroid-refractory chronic graft-versus-host disease: treatment options and patient management
2021 - scholar.archive.org
The use of allogenic hematopoietic stem cell transplant (allo-HSCT) for treatment of
malignant and non-malignant conditions continues to increase annually due to significant …
malignant and non-malignant conditions continues to increase annually due to significant …
Steroid-refractory chronic graft-versus-host disease: treatment options and patient management.
D Wolff, G Fatobene, V Rocha, N Kröger… - Bone Marrow …, 2021 - europepmc.org
Chronic graft-versus-host disease (cGVHD) is one of the major causes of late mortality after
allogenic hematopoietic stem cell transplantation. Moderate-to-severe cGVHD is associated …
allogenic hematopoietic stem cell transplantation. Moderate-to-severe cGVHD is associated …
Steroid-refractory chronic graft-versus-host disease: treatment options and patient management
D Wolff, G Fatobene, V Rocha… - Bone Marrow …, 2021 - epub.uni-regensburg.de
Chronic graft-versus-host disease (cGVHD) is one of the major causes of late mortality after
allogenic hematopoietic stem cell transplantation. Moderate-to-severe cGVHD is associated …
allogenic hematopoietic stem cell transplantation. Moderate-to-severe cGVHD is associated …
Steroid-refractory chronic graft-versus-host disease: treatment options and patient management
D WOLFF, G FATOBENE, V ROCHA, N KROEGER… - 2021 - observatorio.fm.usp.br
Chronic graft-versus-host disease (cGVHD) is one of the major causes of late mortality after
allogenic hematopoietic stem cell transplantation. Moderate-to-severe cGVHD is associated …
allogenic hematopoietic stem cell transplantation. Moderate-to-severe cGVHD is associated …
Steroid-refractory chronic graft-versus-host disease: treatment options and patient management
D Wolff, G Fatobene, V Rocha, N Kröger… - Bone Marrow …, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Chronic graft-versus-host disease (cGVHD) is
one of the major causes of late mortality after allogenic hematopoietic stem cell …
one of the major causes of late mortality after allogenic hematopoietic stem cell …
[引用][C] Steroid-refractory chronic graft-versus-host disease: treatment options and patient management
D WOLFF, G FATOBENE, V ROCHA… - Bone Marrow …, 2021 - observatorio.fm.usp.br
Chronic graft-versus-host disease (cGVHD) is one of the major causes of late mortality after
allogenic hematopoietic stem cell transplantation. Moderate-to-severe cGVHD is associated …
allogenic hematopoietic stem cell transplantation. Moderate-to-severe cGVHD is associated …